Latin America, Middle East and Africa Urinary Incontinence Devices Market Size to register a growth of 12.8% CAGR

08-06-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Urinary Incontinence Devices Market, published by KBV research, the LAMEA Urinary Incontinence Devices Market would witness market growth of 12.8% CAGR during the forecast period (2018 – 2024).

The Brazil market would dominate the LAMEA Foley Catheters Market by 2024, growing at a CAGR of 12.3 % during the forecast period. The Argentina market is expected to witness a CAGR of 12.2% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 9.2% during (2018 - 2024).

The Vaginal Slings market dominated the Argentina Urinary Incontinence Devices Market by Product in 2017, achieving a market value of $24.9 million by 2024. The Urinary Catheters market is expected to witness a CAGR of 13.1% during (2018 - 2024). Additionally, The Other Devices market is expected to witness highest CAGR of 12.7% during (2018 - 2024).

The Internal Urinary Incontinence Devices market dominated the LAMEA Urinary Incontinence Devices Market by Category in 2017. The External Urinary Incontinence Devices market is expected to witness a CAGR of 14.2% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/lamea-urinary-incontinence-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants